Candriam S.C.A. Annexon, Inc. Transaction History
Candriam S.C.A.
- $16.9 Billion
- Q4 2024
A detailed history of Candriam S.C.A. transactions in Annexon, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 2,534,230 shares of ANNX stock, worth $7.12 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,534,230
Previous 2,192,799
15.57%
Holding current value
$7.12 Million
Previous $13 Million
0.15%
% of portfolio
0.08%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$20.8 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$19.7 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17.7 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$15.8 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $134M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...